Please login to the form below

Not currently logged in
Email:
Password:

tuberculosis

This page shows the latest tuberculosis news and features for those working in and with pharma, biotech and healthcare.

Evotec says Sanofi deal makes it anti-infectives powerhouse

Evotec says Sanofi deal makes it anti-infectives powerhouse

regulatory approvals of course – and that will give it “the highest qualified translational footprint in infectious disease research globally.” It will focus initially on antimicrobial resistant (AMR) infections, tuberculosis, and malaria,

Latest news

More from news
Approximately 16 fully matching, plus 106 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    and tuberculosis around the world.

  • The cultural construction of illness The cultural construction of illness

    and ‘consumptive’ appearance, driven by the perception of a link between tuberculosis and creativity.

  • Reactivating drug research programmes Reactivating drug research programmes

    One research-led breakthrough to hit the headlines involves the use of genome sequencing to isolate different strains of tuberculosis (TB), allowing the disease to be diagnosed more quickly.

  • Deal Watch February 2016 Deal Watch February 2016

    acquisition - company. 7, 200. Alere/Abbott Laboratories. portfolio of point of care diagnostics for infections such as HIV, tuberculosis, malaria, dengue.

  • Searching for health Searching for health

    We bring products to the market regularly.”. Success in HIV and multi-drug resistant tuberculosis are the highlights but Quiles is conscious of the need to translate innovation into market penetration.

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics